Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurotoxicity Syndromes × Lorazepam × Other hematologic neoplasm × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neurotoxicity Syndromes 1 Hematologic Neoplasms 1 Delirium 1

Interventions

haloperidol decanoate 1 glutamic acid diethyl ester 1 Vincristine 1 Surveys and Questionnaires 1 Psychiatric Rehabilitation 1 Prednisolone 1 Nutritional Status 1 Methylprednisolone 1 Lorazepam 1 Glutamine 1 Glutamic Acid 1 Exercise 1 Dietary Supplements 1 Cytarabine 1 Baclofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡